Abstract
Since December 2019, COVID-19 has caused huge global
morbidity and mortality.1 Although the disease is primarily
a respiratory illness, gastrointestinal (GI) symptoms are
increasingly recognised.2 However, reported literature on
the prevalence of these symptoms is conflicting, as is their
relationship with disease course and outcome.3,4
We aimed to identify the prevalence of GI symptoms among a
cohort of UK hospitalised adults with confirmed SARS-CoV-2
and to describe the association of GI symptoms with patient
characteristics, clinical course and outcome.
| Original language | English |
|---|---|
| Pages (from-to) | S23-S24 |
| Journal | Clinical Medicine, Journal of the Royal College of Physicians of London |
| Volume | 21 |
| DOIs | |
| Publication status | Published - 21 Mar 2021 |